Cambridge Investment Research Advisors, Inc. Chroma Dex Corp. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Chroma Dex Corp. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 92,650 shares of CDXC stock, worth $508,648. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,650

Previous 114,800 19.29%

Holding current value

$508,648

Previous $313,000 7.99%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$2.51 - $3.8 $55,596 - $84,170	-22,150 Reduced 19.29%	92,650 $338,000
Q2 2024 Jul 26, 2024	SELL	$2.44 - $4.32 $20,740 - $36,720	-8,500 Reduced 6.89%	114,800 $313,000
Q1 2024 Apr 24, 2024	BUY	$1.36 - $3.84 $7,493 - $21,158	5,510 Added 4.68%	123,300 $429,000
Q4 2023 Feb 09, 2024	SELL	$1.28 - $1.6 $6,563 - $8,204	-5,128 Reduced 4.17%	117,790 $168,000
Q3 2023 Oct 24, 2023	SELL	$1.36 - $1.77 $34,578 - $45,002	-25,425 Reduced 17.14%	122,918 $179,000
Q2 2023 Jul 13, 2023	SELL	$1.31 - $1.79 $60,541 - $82,724	-46,215 Reduced 23.75%	148,343 $233,000
Q1 2023 May 11, 2023	BUY	$1.48 - $2.19 $100,640 - $148,920	68,000 Added 53.73%	194,558 $298,000
Q4 2022 Feb 08, 2023	BUY	$1.25 - $1.94 $8,750 - $13,580	7,000 Added 5.85%	126,558 $213,000
Q3 2022 Oct 17, 2022	BUY	$1.19 - $2.06 $32,903 - $56,959	27,650 Added 30.08%	119,558 $0
Q2 2022 Jul 13, 2022	SELL	$1.59 - $2.7 $8,745 - $14,850	-5,500 Reduced 5.65%	91,908 $153,000
Q1 2022 May 12, 2022	BUY	$2.02 - $3.92 $45,450 - $88,200	22,500 Added 30.04%	97,408 $239,000
Q4 2021 Feb 03, 2022	BUY	$3.74 - $6.7 $22,627 - $40,535	6,050 Added 8.79%	74,908 $280,000
Q3 2021 Nov 02, 2021	BUY	$6.05 - $10.41 $302 - $520	50 Added 0.07%	68,858 $431,000
Q2 2021 Aug 10, 2021	BUY	$6.66 - $10.92 $74,425 - $122,031	11,175 Added 19.39%	68,808 $678,000
Q1 2021 May 07, 2021	SELL	$4.59 - $18.74 $124,389 - $507,853	-27,100 Reduced 31.98%	57,633 $538,000
Q4 2020 Feb 04, 2021	BUY	$3.93 - $5.5 $191,587 - $268,125	48,750 Added 135.48%	84,733 $406,000
Q3 2020 Oct 29, 2020	BUY	$4.01 - $5.56 $144,291 - $200,065	35,983 New	35,983 $144,000

Others Institutions Holding CDXC

# of Institutions

Shares Held

17.2M

Call Options Held

66.7K

Put Options Held

8.2K

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $375M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Chroma Dex Corp. Transaction History